Skip to main content


METHYL 1H-PYRAZOLE-3-CARBOXYLATE CAS#: 15366-34-4
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data

Identification

Product NameMETHYL 1H-PYRAZOLE-3-CARBOXYLATEIUPAC Namemethyl 1H-pyrazole-5-carboxylateMolecular StructureCAS Registry Number 462-08-8SynonymsMethyl 1H-pyrazole-3-carboxylate15366-34-4DTXSID10340565DTXCID30291646675-309-2methyl 1h-pyrazole-5-carboxylate1H-Pyrazole-3-carboxylic acid methyl estermethyl pyrazole-3-carboxylate394658-31-22H-Pyrazole-3-carboxylic acid methyl ester3-Methoxycarbonylpyrazole4-Pyrazolecarboxylic Acid Methyl EsterMFCD00649381MFCD04967319pyrazole-3-carboxylic acid methyl ester1H-Pyrazole-3-carboxylic acid, methyl ester5-methoxycarbonylpyrazolemethyl 3-pyrazolecarboxylateSCHEMBL560682methyl 1H-pyrazol-5-carboxylateALBB-003661BCP26620Methyl 1H-pyrazole-3-carboxylate #GEO-01919STK257454AKOS000305749AKOS000321526AC-8946BCP9000067CS-W008807PB10159METHYL 2H-PYRAZOLE-3-CARBOXYLATENCGC00330701-01AC-23119SY013591TS-01651DB-005734M2444Methyl 1H-pyrazole-3-carboxylate, AldrichCPREN300-128969H57052P10300AB01325199-02F0912-0219Z445222298Molecular FormulaC5H6N2O2Molecular Weight126.11InChIInChI=1S/C5H6N2/c6-5-2-1-3-7-4-5/h1-4H,6H2InChI KeyORUCTBNNYKZMSK-UHFFFAOYSA-NSMILESCOC(=O)C1=CC=NN1

Patent InformationPatent IDTitlePublication DateCN119330964Pyrrolopyridine heterocyclic compound, preparation method thereof and application of pyrrolopyridine heterocyclic compound in preparation of medicine for treating Alzheimer disease2025CN117447362Green synthesis method of azobenzene oxide compound2024WO2024/233767INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF2024CN118994022Preparation method and non-classical antibacterial activity application of 1-methyl-4-phenyl ether derivative2024WO2023/288195CD38 MODULATORS AND METHODS OF USE THEREOF2023WO2023/285787SULFUR COMPOUNDS AND PROCESSES AND INTERMEDIATES USEFUL IN THE PREPARATION THEREOF2023CN115838338Method for preparing amide2023

Physical Data

AppearanceWhite powder

Melting Point, °C 60 - 6261.4263 - 6456.361 - 6460 - 6361

Boiling Point, °C251250 - 252

Density, g·cm-3Reference Temperature, °CMeasurement Temperature, °C1.144251.24-1901.24

Description (Association (MCS))Adsorption isotherm

Spectra

Description (NMR Spectroscopy)Nucleus (NMR Spectroscopy)Solvents (NMR Spectroscopy)Frequency (NMR Spectroscopy), MHzChemical shifts, Spectrum13Cchloroform-d1151Chemical shifts, Spectrum1Hchloroform-d1599Chemical shifts, Spectrum1Hchloroform-d1Chemical shifts, Spectrum13Cchloroform-d1Chemical shifts, Spectrum13Cchloroform-d1Chemical shifts, Spectrum1Hchloroform-d1Chemical shifts, Spectrum13Cchloroform-d1

Description (IR Spectroscopy)Solvent (IR Spectroscopy)ATR (attenuated total reflectance), BandsBands, Spectrumpotassium bromideSpectrumBandsIntensity of IR bands, Bands, SpectrumBandspotassium bromide

Description (UV/VIS Spectroscopy)Solvent (UV/VIS Spectroscopy)Comment (UV/VIS Spectroscopy)Absorption Maxima (UV/VIS), nmExt./Abs. Coefficient, l·mol-1cm-1SpectrumSpectrumwaterSpectrumchloroformAbsorption maximaH2O, H2SO4Ratio of solvents: 66percent2585740Absorption maximaH2O, H2SO4Ratio of solvents: 66percent2585730Absorption maximaH2O233, 2928070, 2960Absorption maximaH2O, NaOHRatio of solvents: 0.1N232, 2908600, 3120

Route of Synthesis (ROS)

Route of Synthesis (ROS) of Methyl 1H-pyrazole-3-carboxylate CAS 15366-34-4

ConditionsYieldWith tert.-butylnitrite; trimethylsilylazide In acetonitrile at 0 - 20℃; for 2h;100%Stage #1: pyridin-3-ylamine With hydrogenchloride; sodium nitrite In water for 0.5h; Cooling with ice;Stage #2: With sodium azide In water at 20℃; for 2h; Cooling with ice;Experimental Procedure4.1.1 General procedure for the preparation of compounds 2a-eGeneral procedure: Aniline (931mg, 10mmol) was dissolved with HCl (6mol·L-1, 10mL) in an ice bath. NaNO2 (1035mg, 15mmol) dissolved in 25mL water was added dropwise. The reaction mixture was stirred for 30min. Sodium azide (2600mg, 40mmol) dissolved in 50mL water was added dropwise. After this addition, the system was stirred for another 2h at room temperature. Then, the mixture was extracted with ethyl acetate and the combined organic extracts were washed with H2O, dried over anhydrous Na2SO4, filtered, and concentrated in vacuo to give 2a (1190mg, 100%) as yellow oil. The crude product was used directly without purification. Compounds 2b, 2c, 2d, 2e were obtained with 1b, 1c, 1d, 1e respectively by using the same method that described above.95%Stage #1: pyridin-3-ylamine With sulfuric acid; sodium nitrite In water at 0 - 55℃; for 0.416667h;Stage #2: With urea In water for 0.333333h;Stage #3: With sodium azide In water at 20℃; for 1.5h;Experimental Procedure1.2 3-(1H-1,2,3-Triazol-4-yl)pyridine (2)To a solution of 3.6 mL of H2SO4 98% wt and 21.0 mL of water heated at 55 °C, 3-aminopyridine (1.89 g, 20.10 mmol, 1 eq) was added.After 5 min, the solution was cooled at 0 °C and a solution of sodium nitrite (1.66 g, 2.41 mmol, 1.2 eq in 14.0 mL of water) was added dropwise.After 20 min, urea was added (0.24 g, 4.00 mmol, 0.2 eq) and after 20 min a solution of NaN3 (1.65 g, 24.00 mmol, 1.2 eq in 15 mL of water) was added dropwise.The reaction was then stirred at room temperature for 1.5 h and then quenched with saturated aqueous NaHCO3 and extracted with diethyl ether (*3).Evaporation of the solvent gave a brown oil which was enough pure to be used for the next step without purification (95%).1H NMR (300 MHz, CDCl3) δ 8.23-8.19 (m, 2-H), 7.17-7.12 (m, 2-H); 13C NMR (75 MHz, CDCl3) δ 145.9, 141.2, 137.0, 125.8, 124.1.95%

Safety and Hazards

Pictogram(s)SignalWarningGHS Hazard StatementsH315 (100%): Causes skin irritation H319 (100%): Causes serious eye irritation H335 (80%): May cause respiratory irritation Precautionary Statement CodesP261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501(The corresponding statement to each P-code can be found at the GHS Classification page.)

Other Data

TransportationUnder the room temperature and away from lightHS CodeStorageUnder the room temperature and away from lightShelf Life2 years

DruglikenessLipinski rules componentMolecular Weight94.116logP-0.047HBA2HBD1Matching Lipinski Rules4Veber rules componentPolar Surface Area (PSA)38.91Rotatable Bond (RotB)0Matching Veber Rules2 https://www.chemwhat.com/methyl-1h-pyrazole-3-carboxylate-cas-15366-34-4/

Comments

Post a Comment

Popular posts from this blog

Overcoming the "Choke Points" in Semaglutide Side Chain Synthesis with Core Technologies to Enable Efficient GLP-1 Drug Manufacturing

Semaglutide, a groundbreaking product in the GLP-1 drug class, owes its extended half-life and enhanced receptor affinity largely to its unique side chain, Ste-Glu-AEEA-AEEA-OSU (CAS: 1169630-40-3) . This side chain covalently modifies the peptide backbone, significantly improving pharmacokinetics and therapeutic performance. However, its complex structure presents two critical synthetic challenges: Precise Assembly of Repetitive AEEA Units: The side chain features consecutive AEEA (aminoethoxyethoxyacetic acid) units, which require stepwise coupling via highly activated intermediates (e.g., AEEA-AEEA). Any impurities or deviations compromise downstream reaction efficiency and may trigger irreversible byproducts. Stereochemistry and Stability of Glutamic Acid (Glu): The glutamic acid component must maintain strict L-configuration, and its carboxyl groups require directional protection (e.g., OtBu) to preserve biological activity. Leveraging deep expertise in peptide chemistry a...
Post a Comment
Read more
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data Identification Product NameTETRAKIS(ETHYLMETHYLAMINO)HAFNIUM IUPAC Nameethyl(methyl)azanide;hafnium(4+) Molecular StructureCAS Registry Number 352535-01-4MDL NumberMFCD03427130Synonyms352535-01-4Tetrakis(ethylmethylamino)hafniumEthanamine, N-methyl-, hafnium(4+) salt (4:1)ethyl(methyl)azanide;hafnium(4+)MFCD03427130SCHEMBL237323Hafnium tetrakis(ethylmethylamide)Tetrakis(ethylmethylamido)hafnium(IV)Tetrakis(ethylmethylamino)hafnium 99.999%Tetrakis(ethylmethylamido)hafnium(IV), >=99.99% trace metals basisTetrakis(ethylmethylamido)hafnium(IV), packaged for use in deposition systemsMolecular FormulaC12H32HfN4Molecular Weight410.9InChIInChI=1S/4C3H8N.Hf/c4*1-3-4-2;/h4*3H2,1-2H3;/q4*-1;+4 InChI KeyNPEOKFBCHNGLJD-UHFFFAOYSA-NIsomeric SMILESCCC.CCC.CCC.CCC. Physical Data AppearanceColorless liquid Spectra No data available Route of Synthesis (ROS) Route of Synthesis (ROS) of TETRAKIS(ETHYLMETHYLAMINO)HAF...
Post a Comment
Read more
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data Identification Product NameBCTA-4NH2IUPAC NameMolecular StructureCAS Registry Number 2559708-42-6Synonyms4,4',4",4"'-(-3,3',6,6'-tetrayl)tetraanilineMolecular FormulaC48H36N6Molecular Weight696.86 Physical Data AppearanceYellow to white powder Spectra No data available BCTA-4NH2 CAS#：2559708-42-6 NMR Route of Synthesis (ROS) No data available Safety and Hazards No data available Other Data TransportationStore at 2-8°C away from light for long time storageStore at 2-8°C away from light for long time storageHS CodeStorageStore at 2-8°C away from light for long time storageShelf Life1 yearMarket Price Toxicity/Safety PharmacologyQuantitative Results Use PatternBCTA-4NH2 CAS#: 2559708-42-6 is an organic compound with a wide range of applications. One of its primary uses is in the field of organic electronics, where it is used as a hole-transport material in organic light-emitti...
Post a Comment
Read more